Bortezomib-pinanediol
Inquiry
| Post Date: | Sep 08,2016 |
| Expiry Date: | Mar 07,2017 |
| Detailed Description: | Cas No. :205393-22-2 |
| CAS Registry Number: | 205393-22-2 |
| Synonyms: | ;Bortezomib pinanediol ester;n-[(1s)-2-[[(1r)-1-[(3as,4s,6s,7ar)-hexahydro-3a,5,5-trimethyl-4,6-methano-1,3,2-benzodioxaborol-2-yl]-3-methylbutyl]amino]-2-oxo-1-(phenylmethyl)ethyl]-2-pyrazinecarboxamide;n-[(1s)-1-benzyl-2-({(1r)-3-methyl-1-[(1s,2s,6r,8s)-2,9,9-trimethyl-3,5-dioxa-4-boratricyclo[6.1.1.0~2,6~]dec-4-yl]butyl}amino)-2-oxoethyl]-2-pyrazinecarboxamide;bortezomib intermediates iii;Bortezomib Intermediate III; |
| Molecular Formula: | C29H39BN4O4 |
| Molecular Weight: | 518.46 |
| Molecular Structure: | 
|
| Company: | Taizhou canova Bio-technology Co.,Ltd. [ China ] |
| Contact: | |
| Tel: | +86-576-81122208/81101151/8110 |
| Fax: | +86-576-81122207 |
| Email: | canova@canova.com.cn |
-
Disclaimer statement:The information and data included above have been realized by the enterprises and compiled by the staff, and are subject to change without notice to you. The Chemnet makes no warranties or representations whatsoever regarding the facticity, accuracy and validity of such information and data. In order to ensure your interest, we suggest you chose the products posted by our gold suppliers or VIP members.
